Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:01 PM ET 10-Q
Financial Results Phillip Street BDC LLC

Phillip Street BDC Q3 2026 Results: Net Income $11.8M, Up 6.4% YoY

For the nine months ended September 30, 2026, Phillip Street BDC LLC reported total investment income of $67.6 million and net investment income of $38.3 million. Total members' capital increased to $572.1 million, with a net asset value per unit of $20.12, up from $19.83 at the end of 2025.

Key figure
Net income $11.8M · +6.4% YoY
5:01 PM ET 10-Q
Financial Results Elutia Inc. ELUT

Elutia Q3 2026 Results: Net Loss of $1.28M, Loss Narrows

Elutia Inc. is focusing on the development of its next-generation biologic scaffolds, NXT-41 and NXT-41x, following the divestiture of its SimpliDerm and Orthobiologics businesses. The company is managing ongoing litigation related to its FiberCel and VBM product recalls while navigating capital requirements and Nasdaq compliance.

Key figure
Net loss $1.28M
5:01 PM ET 10-Q
Financial Results Silver Capital Holdings LLC

Silver Capital Holdings Q3 2026 Results: Net Loss of $10.9M

Silver Capital Holdings LLC reported a net decrease in net assets resulting from operations of $17.93 million for the nine months ended September 30, 2026, primarily driven by $37.98 million in net unrealized depreciation. Total investment income decreased significantly to $18.98 million from $44.22 million in the prior year period, while the company's net asset value per unit fell to $18.62 from $21.46 at year-end 2025.

Key figure
Net loss $10.9M
5:01 PM ET 8-K
Financial Results Eastern Co EML

Eastern Financial Results

The Eastern Company reported a 36% year-over-year increase in net sales to $75.0 million for the third quarter of 2026, driven by organic growth in truck mirror assemblies and the first full quarter of contributions from Sungear and Crown Precision. Net income from continuing operations rose significantly to $3.4 million, or $0.57 per diluted share, while the company's backlog grew 70% to $126.1 million. Management highlighted the benefits of restructuring initiatives and improved demand across aerospace, defense, and commercial transportation markets.

Term
Q3 2026

“The third quarter showed what Eastern can deliver when the benefits of our restructuring initiatives implemented over the past year are combined with improving demand.”

Ryan Schroeder, Eastern’s President and CEO

“Our job from here is execution: convert the backlog, protect our margins, and stay disciplined on capital, including acquisitions that complement our core strengths and enhance long-term value.”

Ryan Schroeder, Eastern’s President and CEO
5:01 PM ET 10-Q
Financial Results Stellar V Capital Corp. (Cayman Islands) SVCC

Stellar V Capital Q3 2026 Results: Net Income $936K, Down 37.4% YoY

Stellar V Capital Corp. reported a net income of $2.96 million for the nine months ended September 30, 2026, primarily driven by $4.24 million in interest earned on marketable securities held in the Trust Account. The company remains a shell entity with $160.97 million in Class A ordinary shares subject to possible redemption and is actively seeking a target for its initial business combination.

Key figure
Net income $936K · -37.4% YoY
5:00 PM ET 8-K
Financial Results Dolphin Entertainment, Inc. DLPN

Dolphin Entertainment Financial Results

Dolphin Entertainment reported record quarterly revenue of $16.0 million for Q3 2026, an 8.3% year-over-year increase. The company achieved profitability with net income of $0.2 million and a 42.9% increase in Adjusted EBITDA to $1.6 million, driven by organic growth and improved operating leverage.

Term
Q3 2026

“Dolphin had an outstanding third quarter. Revenue for the quarter grew 8.3% year-over-year to $16.0 million, the highest quarterly revenue in Dolphin’s history, even including Q1 2024 when we reported $3.4 million from Blue Angels.”

Bill O’Dowd, CEO of Dolphin

“We reported net income of $0.2 million, compared to a net loss of $0.4 million a year ago, and adjusted EBITDA increased 42.9% to $1.6 million versus $1.1 million a year ago.”

Bill O’Dowd, CEO of Dolphin
4:59 PM ET 10-Q
Financial Results Goldman Sachs Private Middle Market Credit II LLC

Goldman Sachs Private Middle Market Credit II Q3 2026 Results: Net Income $2.65M, Down 83.7% YoY

For the nine months ended September 30, 2026, Goldman Sachs Private Middle Market Credit II LLC reported total investment income of $113.26 million and net investment income of $70.61 million. The company experienced significant net unrealized depreciation of $55.19 million across its investment portfolio, contributing to a net asset value per unit of $65.20 compared to $68.62 at the end of 2025.

Key figure
Net income $2.65M · -83.7% YoY
4:59 PM ET 10-Q
Financial Results U.S. GoldMining Inc. USGO

U.S. GoldMining Q3 2026 Results: Net Loss of $8.19M, Loss Widens

U.S. GoldMining Inc. reported a significant increase in net loss to $14.3 million for the nine months ended September 30, 2026, compared to $5.0 million in the prior year, primarily driven by a surge in exploration expenses at the Whistler Project. The company remains in the exploration stage with no revenue, relying on equity financing including At-The-Market and registered direct offerings to fund its operations.

Key figure
Net loss $8.19M
4:59 PM ET 10-Q
Financial Results Netlist Inc NLST ▶ Call

Netlist Q3 2026 Results: Turns Profitable, Net Income $85.4M

Netlist reported a significant increase in net sales to $105.1 million for the third quarter of 2026, driven by a $44.9 million license fee and strong product sales. The company achieved a net income of $85.4 million for the quarter, aided by a $44.0 million income tax benefit and a substantial increase in deferred revenue.

Key figure
Net income $85.4M
4:58 PM ET 10-Q
Financial Results Resideo Technologies, Inc. REZI ▶ Call

Resideo Technologies Q3 2026 Results: Net Income $22M, Down 85.9% YoY

Resideo Technologies reported a net income of $22 million for the third quarter of 2026, a significant decrease from $156 million in the prior year period. The company completed the ADI Spin-Off during the period, resulting in a substantial reduction in total assets from $8.4 billion to $4.1 billion and a shift to a retained deficit of $1.4 billion.

Key figure
Net income $22M · -85.9% YoY
4:58 PM ET 10-Q
Financial Results Veradermics, Inc MANE

Veradermics Q3 2026 Results: Net Loss of $21M, Loss Widens

Veradermics, Inc. is a clinical-stage biopharmaceutical company focused on developing VDPHL01 for pattern hair loss. As of November 5, 2026, the company had 42,195,472 shares of common stock outstanding and continues to incur substantial losses with no products yet approved for commercial sale.

Key figure
Net loss $21M
4:56 PM ET 10-Q
Financial Results Apollo Origination II (UL) Capital Trust

Apollo Origination II Q3 2026 Results: Net Income $14.7M, Up 12.8% YoY

Apollo Origination II (UL) Capital Trust reported total investment income of $44.87 million for the nine months ended September 30, 2026, compared to $34.44 million in the prior year period. Net asset value per share decreased slightly to $25.39 from $25.55 at year-end 2025, primarily driven by net change in unrealized losses on investments.

Key figure
Net income $14.7M · +12.8% YoY
4:56 PM ET 10-Q
Financial Results Gevo, Inc. GEVO ▶ Call

Gevo Q3 2026 Results: Turns Profitable, Net Income $22.7M

Gevo, Inc. reported a significant net loss of $172.5 million for the nine months ended September 30, 2026, primarily driven by a $135.8 million impairment of long-lived assets and a $40.3 million allowance for credit losses. Despite these charges, total revenues grew to $172.4 million compared to $115.2 million in the prior year period, and the company generated positive cash flow from operations of $12.0 million.

Key figure
Net income $22.7M
4:55 PM ET 10-Q
Financial Results Apollo Origination II (Levered) Capital Trust

Apollo Origination II Q3 2026 Results: Net Income $21.3M, Up 13.4% YoY

For the nine months ended September 30, 2026, Apollo Origination II (Levered) Capital Trust reported total investment income of $101.9 million and net investment income of $51.3 million. Total net assets grew to $835.9 million, driven by $105 million in net proceeds from common share issuances, despite a net change in unrealized losses of $12.4 million during the period.

Key figure
Net income $21.3M · +13.4% YoY
4:53 PM ET 10-Q
Financial Results T Series BDC LLC

T Series BDC Q3 2026 Results: Net Income $9.25M, Down 59.7% YoY

T Series BDC LLC's Form 10-Q for the period ended September 30, 2026, details its financial performance and investment activity as a business development company. The filing highlights net investment income, changes in net assets from operations, and the current fair value of its private debt and equity portfolio.

Key figure
Net income $9.25M · -59.7% YoY
4:52 PM ET 10-Q
Financial Results Petmed Express Inc PETS

Petmed Express Q2 2026 Results: Net Loss of $6.43M, Loss Narrows

PetMed Express reported a significant decline in net sales of 19.6% for the six months ended September 30, 2026, resulting in a net loss of $12.6 million. Management identified substantial doubt about the company's ability to continue as a going concern due to declining cash balances and ongoing operating losses, though they believe strategic cost reductions and marketing optimizations will alleviate these concerns.

Key figure
Net loss $6.43M
4:51 PM ET 8-K
Financial Results Gossamer Bio, Inc. GOSS

Gossamer Bio Financial Results

Gossamer Bio reported Q3 2026 financial results, highlighting the submission of its first New Drug Application (NDA) to the FDA for seralutinib in PAH. The company also noted a structured private placement that provided $25 million upfront and could unlock an additional $125 million upon FDA acceptance of the NDA. Additionally, the company completed a 1-for-80 reverse stock split in September 2026 to regain Nasdaq compliance.

Term
Q3 2026

“Submitting our first NDA marks an important milestone for Gossamer in our continued efforts to bring seralutinib to patients living with PAH. Furthermore, FDA acceptance of the application in 2026 would, subject to other customary closing conditions, unlock up to approximately $125 million in additional committed capital to support our priorities, including preparations for a potential launch. We remain focused on supporting the FDA’s review and preparing for a potential commercial launch of seralutinib in 2027.”

Faheem Hasnain, Chairman, Co-Founder and Chief Executive Officer
4:51 PM ET 10-Q
Financial Results Abvc Biopharma, Inc. ABVC

Abvc Biopharma Q3 2026 Results: Turns Profitable, Net Income $1.15M

ABVC BioPharma reported accrued research and development expenses of $1,741,083 as of September 30, 2026, primarily for manufacturing and process development. The company noted potential increases in future accruals due to the planned resumption of ophthalmology and CNS clinical trials.

Key figure
Net income $1.15M
4:49 PM ET 10-Q
Financial Results Gossamer Bio, Inc. GOSS

Gossamer Bio Q3 2026 Results: Net Loss of $48.1M, Loss Narrows

Gossamer Bio reported total revenue of $64.6 million for the nine months ended September 30, 2026, compared to $34.7 million in the prior year, primarily driven by collaboration contracts. Despite the revenue growth, the company recorded a net loss of $77.8 million for the period, impacted by significant non-cash items including a $54.9 million remeasurement of warrant liability and a $43.8 million gain on debt extinguishment.

Key figure
Net loss $48.1M
4:48 PM ET 10-Q
Financial Results Autolus Therapeutics plc AUTL

Autolus Therapeutics Q3 2026 Results: Net Loss of $55.1M, Loss Narrows

Autolus Therapeutics plc, a foreign private issuer voluntarily filing a Form 10-Q, reported 266,340,330 ordinary shares outstanding as of November 9, 2026. The filing highlights the commercialization of AUCATZYL for adult r/r B-ALL and notes a restructuring and workforce reduction plan initiated in April 2026.

Key figure
Net loss $55.1M
4:48 PM ET 10-Q
Financial Results Metropolitan Life Insurance Co

Metropolitan Life Insurance Q3 2026 Results: Net Income $1.5B, Up 190.1% YoY

Metropolitan Life Insurance Company reported total assets of $375.9 billion as of September 30, 2026, a decrease from $383.5 billion at year-end 2025. Stockholder's equity declined to $12.4 billion, primarily driven by an increase in accumulated other comprehensive loss, while the company continues to operate as a wholly-owned subsidiary of MetLife, Inc. under a reduced disclosure format.

Key figure
Net income $1.5B · +190.1% YoY
4:47 PM ET 10-Q
Financial Results Hyliion Holdings Corp. HYLN

Hyliion Holdings Q3 2026 Results: Net Loss of $11.1M, Loss Narrows

Hyliion Holdings Corp. reported a net loss of $11.1 million for the third quarter of 2026, an improvement from the $13.3 million loss in the prior year period. Total revenues grew significantly to $7.5 million, primarily driven by research and development services, while the company continues to transition its focus toward the KARNO Power Module technology.

Key figure
Net loss $11.1M
4:47 PM ET 8-K
Financial Results Azenta, Inc. AZTA

Azenta Financial Results

Azenta reported fiscal fourth quarter and full year 2026 results, with Q4 revenue growing 5% year-over-year to $167 million. The company completed the sale of its B Medical Systems business during the year and is focusing on driving organic growth and profitability in its Multiomics and Sample Management segments for fiscal 2027.

Term
FY2026

“We closed fiscal 2026 with improving momentum, delivering stronger performance in the second half of the year. Our businesses have strong market positions and differentiated capabilities, and we are seeing progress from our efforts to improve commercial execution and operating efficiency.”

Dr. Martin Madaus, Interim President and Chief Executive Officer

“Fiscal 2027 is about consistent execution and accelerating performance. We are focused on driving organic growth, expanding profitability and cash generation, and executing on our strategic initiatives.”

Dr. Martin Madaus, Interim President and Chief Executive Officer
4:46 PM ET 10-Q
Financial Results North Haven Private Income Fund A LLC

North Haven Private Income Fund A Q3 2026 Results: Net Income $4.79M, Down 27.2% YoY

North Haven Private Income Fund A LLC reported a net increase in members' capital resulting from operations of $12.4 million for the nine months ended September 30, 2026, down from $16.9 million in the prior year period. The decrease was primarily driven by $9.1 million in net realized and unrealized losses, which offset a significant rise in total investment income to $40.8 million.

Key figure
Net income $4.79M · -27.2% YoY
4:46 PM ET 8-K
Financial Results Hyliion Holdings Corp. HYLN

Hyliion Holdings Financial Results

Hyliion Holdings reported Q3 2026 revenue of $7.5 million and increased its full-year 2026 revenue guidance to approximately $18 million. The company delivered an early adopter KARNO Power Module to the U.S. Navy and expects to secure approximately $50 million in total military contract awards for the full year.

Term
Q3 2026

“We delivered another strong quarter, with revenue well above our expectations and continued progress on system performance and customer deployments. We delivered another system to the Navy and began moving equipment to our first commercial customer site, where we expect to complete the deployment in the weeks ahead.”

Thomas Healy, Founder and CEO
4:46 PM ET 10-Q
Financial Results Beachbody Company, Inc. BODI

Beachbody Company Q3 2026 Results: Net Income $3.28M, Down 8.1% YoY

Beachbody reported a net income of $6.95 million for the nine months ended September 30, 2026, a significant improvement from the $8.08 million net loss in the prior year period. Total revenue decreased from $196.2 million to $149.1 million year-over-year, but the company achieved profitability through substantial reductions in selling, marketing, and general administrative expenses.

Key figure
Net income $3.28M · -8.1% YoY
4:46 PM ET 10-Q
Financial Results Sanuwave Health, Inc. SNWV

Sanuwave Health Q3 2026 Results: Net Loss of $1.42M

SANUWAVE Health reported a net operating loss of $2.5 million for the nine months ended September 30, 2026, compared to an operating income of $2.9 million in the prior year period. Total revenue decreased to $27.9 million from $30.7 million, while operating expenses increased primarily due to higher research and development and selling costs.

Key figure
Net loss $1.42M
4:45 PM ET 10-Q
Financial Results Koru Medical Systems, Inc. KRMD

Koru Medical Systems Q3 2026 Results: Turns Profitable, Net Income $218K

KORU Medical Systems reported net revenues of $11.6 million for the quarter ended September 30, 2026, representing growth over the $10.4 million reported in the prior year period. The company achieved a net income of $0.2 million for the quarter, a significant improvement from the $0.8 million net loss in the same period of 2025.

Key figure
Net income $218K
4:44 PM ET 8-K
Financial Results Tandy Leather Factory Inc TLF

Tandy Leather Factory Financial Results

Tandy Leather Factory reported third quarter 2026 revenues of $18.5 million, a 7.3% increase year-over-year, and returned to profitability with net income of $0.5 million. The company highlighted operational improvements and store expansions in Waco, Texas, and Charleston, South Carolina, as key drivers of the 181.9% increase in operating income.

Term
Q3 2026

“We are happy to have continued our growth from the first half of the year with another strong quarter. We saw growth in both retail and e-commerce channels and considerably increased our operating income. Following our new store opening in Waco, Texas in the second quarter, we continued our store expansion in the third quarter with a new opening in Charleston, South Carolina. During the third quarter, we continued to invest in our store fleet, our e-commerce channel and operations but our sales and margin growth more than offset these expenses, driving strong increases in profit from operations.”

Johan Hedberg, Chief Executive Officer
4:44 PM ET 8-K
Financial Results Koru Medical Systems, Inc. KRMD

Koru Medical Systems Financial Results

KORU Medical Systems reported Q3 2026 net revenues of $11.6 million, an 11% increase year-over-year, and achieved its second consecutive quarter of positive net income. The company revised its full-year 2026 revenue guidance to $48.0-$48.5 million and highlighted growth in domestic core revenues driven by higher pump and consumable volumes.

Term
Q3 2026

“Total Revenue of $11.6 million represents another quarter of consistent above-market growth for KORU, driven by our recurring patient base. We also delivered positive net income and adjusted EBITDA for the second consecutive quarter, demonstrating the scalability of our business model.”

Adam Kalbermatten, President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.